Acute kidney injury: Novel biomarkers and potential utility for patient care in urology

Anil A. Thomas, Sevag Demirjian, Brian R. Lane, Matthew N. Simmons, David A. Goldfarb, Vairavan S. Subramanian, Steven C. Campbell

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Abstract

Urologists are integrally involved in the management of acute kidney injury (AKI), which is common after renal surgery or secondary to postrenal (obstructive) etiologies. The measurement of serum creatinine is a suboptimal indicator of AKI because it lags behind acute changes in renal function. Recent advances indicate that serum/urine biomarkers will prove useful for early detection of AKI, analogous to the use of cardiac enzymes for acute myocardial infarction. These serum/urine markers may guide future therapy, facilitate research efforts to reduce the severity of AKI, such as after partial nephrectomy, and allow for more accurate prognostication for patients with AKI.

Original languageEnglish (US)
Pages (from-to)5-11
Number of pages7
JournalUrology
Volume77
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Acute kidney injury: Novel biomarkers and potential utility for patient care in urology'. Together they form a unique fingerprint.

Cite this